JUDITH HAHN: Open Payments
NPI 1700974581 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$936 in 42 payments from 8 companies in 2025. Trend: 2023 $723 · 2024 $947 · 2025 $936
Food & beverage: $860Education: $76
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 16 | $241 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $190 |
| Neurocrine BioSciences, Inc. | 5 | $148 |
| Teva Pharmaceuticals USA, Inc. | 3 | $128 |
| Alkermes, Inc. | 4 | $103 |
| Vanda Pharmaceuticals Inc. | 2 | $58 |
| ABBVIE INC. | 3 | $45 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
Products named: REXULTI, CAPLYTA, INGREZZA, LYBALVI, AUSTEDO XR, ARISTADA, VRAYLAR, HETLIOZ.
Industry payments across AZ — which companies pay providers there.
